Simplicity Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
10,730
+2,816
+36% +$371K 0.05% 356
2026
Q1
$1.1M Sell
7,914
-707
-8% -$99K 0.06% 277
2025
Q4
$1.06M Buy
8,621
+142
+2% +$17.3K 0.06% 268
2025
Q3
$941K Sell
8,479
-2,629
-24% -$299K 0.05% 307
2025
Q2
$1.23M Buy
11,108
+6,802
+158% +$724K 0.05% 293
2025
Q1
$483K Buy
+4,306
New +$444K 0.04% 346
2024
Q3
Sell
-21,064
Closed -$1.45M 764
2024
Q2
$1.45M Sell
21,064
-763
-3% -$50.9K 0.03% 425
2024
Q1
$1.6M Buy
+21,827
New +$1.68M 0.04% 397

Other funds holding GILD

Simplicity Wealth's GILD Position: Q2 2026 in Review

Simplicity Wealth increased its Gilead Sciences (GILD) stake by 36% in Q2 2026, buying an estimated $371K and bringing the position to 10,730 shares worth $1.36M. The position accounts for 0.05% of the portfolio, ranked #356.

Simplicity Wealth first reported a position in GILD in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.6M in Q1 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Simplicity Wealth held 10,730 shares of Gilead Sciences worth $1.36M as of Q2 2026.
  • Simplicity Wealth bought 2,816 Gilead Sciences shares in Q2 2026, an estimated $371K.
  • Gilead Sciences made up 0.05% of Simplicity Wealth's portfolio in Q2 2026, its #356 holding.
  • Simplicity Wealth first reported a position in Gilead Sciences in Q1 2024 and has held it in 8 quarters since.
  • Simplicity Wealth's Gilead Sciences position peaked at $1.6M in Q1 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.